ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2022 American Transplant Congress

June 4-8, 2022 in Boston, MA

The ATC program is built in the Eastern Time Zone.

View by Title View Sessions View Topics
View by Date
Jump to:  View All • a b c d [e] f g h i j k l m n o p q r s t u v w x y z
  • Early Clinical Complications Following HLA-Incompatible Living Donor Kidney Transplantation

    J. D. Motter1, K. Jackson1, A. Massie1, J. Garonzik-Wang2, D. Segev1

  • Early Clinical Experience With Alvr109, A Partially Hla-matched Sars-cov-2 Specific T-cell Therapy, In Immunocompromised Patients With Covid-19

    G. Haidar1, J. Jacobs2, K. Hughes2, K. McCormick2, A. Naqvi2, M. Agha2, T. Bogdanovich2, B. Johnson2, J. Kozar2, E. Lendermon2, C. Marino2, A. Raptis2, F. Silveira2, W. Marshall3, M. Miller3, E. Atillasoy3, J. Mellors2

  • Early Clinical Experience With Nirmatrelvir/ritonavir For Treatment Of Covid-19 In Solid Organ Transplant Recipients

    D. Salerno1, D. Jennings2, N. Lange3, D. Kovac1, T. Shertel1, J. Chen4, J. Hedvat5, J. Scheffert1, R. S. Brown6, M. Pereira7

  • Early Detection of Acute Rejection by Urine QSant is Not Confounded by Post-Transplant Time

    C. Baan1, S. Ghosh2, J. Verhoeven1, D. Hesselink1, K. Boer1, M. Sarwal2

  • Early Evaluation Of The Impact Of Change In UNet Organ Refusal Code Reasons On Us Transplant Center Organ Offers

    S. Noreen1, C. Martinez1, S. Mohan2, K. McCharen1, A. Placona1, R. Patzer3

  • Early Experience Of 48-hour Normothermic Machine Perfusion In Human Kidneys Applying Urine Recirculation

    F. Messner1, S. Gasteiger1, M. Pühringer-Sturmayr1, A. Soleiman1, D. Öfner1, S. Schneeberger1, A. Weissenbacher2

  • Early Experience with 4-drug Maintenance Immunosuppression in Kidney and Pancreas Transplant Recipients

    S. Mouawad1, C. Shoemaker2, J. Geyston3, A. Nishio Lucar3

  • Early Experience with OmniGraf® Biomarker Surveillance in Kidney Transplant Patients in the First-Year Post-Transplant and Beyond

    V. Paramasivam1, W. Ally2, B. Sivakumar3, B. Greco1, M. Germain1

  • Early Experience with Varicella Vaccination in Pediatric Heart Transplant Recipients

    A. Dipchand, M. Seifert-Hansen

  • Early Experiences with Developing the Techniques of Pure Laparoscopic Explant Hepatectomy without Fragmentation in Living Donor Liver Transplantation

    S. Hong1, C. Kim1, S. Lee2, S. Suh2, S. Hong1, E. Han1, Y. Choi3, N. Yi2, K. Lee3, K. Suh1

  • Early Il-33 Action on Myeloid Cells is Critical In Resistance to Systemic Candida Albicans Infection

    H. Cho1, S. Park1, B. Kwon2, H. Park1, Y. Kim3, J. Lee4, J. Park4, K. Park4, K. Yoo4

  • Early Impact of the Mission Act on Utilization of Veterans Affairs Transplant Centers

    J. C. Walker1, C. Roumie2, I. D. Feurer3, R. Forbes4

  • Early Kidney Transplantation Irrespective of Donor Profile Offers Survival Benefit in Recipients Older Than 70 Years

    A. Mujkanovic1, T. Jarmi2, C. B. Taner1, K. P. Croome1, S. A. Mao1

  • Early Mortality After Liver Transplant is Associated with Pre-Transplant Alterations in Monocyte Phenotype and Gene Expression

    L. Jin1, A. Lemenze2, G. Panayotova1, S. Simonishvili1, Y. Qin1, T. Ayorinde1, G. Prakash1, L. J. Minze3, F. Paterno1, L. Brown1, A. Amin1, X. C. Li3, R. Ghobrial3, J. V. Guarrera1, K. E. Lunsford1

  • Early Outcomes for Liver Transplant with Thoracoabdominal Normothermic Regional Perfusion for Donation After Circulatory Death: A Multi-Center Experience

    A. L. Brubaker1, A. Lee1, B. Jackson1, J. Berumen1, J. R. Parekh1, K. L. Mekeel1, A. R. Gupta2, J. M. Gardner2, T. Chaly3, A. K. Mathur4, C. Jadlowiec4, K. Reddy4, R. Nunez4, J. Bellingham5, E. Thomas6, J. R. Wellen7, M. Kearns1, V. Pretorius1, G. T. Schnickel1

  • Early Outcomes of Kidney Transplant Recipients from Donors with Severe Sars-cov-2 Pneumonia

    M. Rosenzweig, M. Finotti, A. Gupta, S. Lee, N. Onaca, G. J. McKenna, J. Bayer, H. Fernandez, R. Ruiz, E. Martinez, A. Yango, T. Sam, C. Spak, B. Fischbach, G. Testa, A. Wall

  • Early Outcomes of Single Dose Eculizumab for Abo-Incompatible Living Donor Renal Transplantation

    K. Heagler, M. Campara, P. Di Cocco, S. Gaitonde, I. Tang, J. Almario Alvarez, M. Spaggiari, J. Benken, C. S. Muran, B. Valdepenas, D. Pierce, I. Tzvetanov, E. Benedetti

  • Early Outcomes Since Implementation of New Kidney Allocation System

    K. Shah, F. Siddiqui, P. N. Chotai, A. Logan, A. Schenk, K. Washburn, A. Limkemann

  • Early Post-Operative Thrombotic Microangiopathy in Deceased Donor Kidney Transplant: A Retrospective Case Series

    R. Seneriz1, A. Mattiazzi1, G. Guerra1, T. Harrington2, M. Velasquez3

  • Early Retrieval of the Right Kidney for Combined Heart and Kidney Transplantation is Feasible and Reduces Costs

    H. Podder1, R. McMillan2, S. Yi2, M. Hobeika3, D. Nguyen2, E. Graviss2, R. Whitehead2, R. J. Knight4, M. Ghobrial2, A. O. Gaber2

  • Early Tacrolimus Exposure is Associated with BK-Viremia in Kidney Transplant Recipients

    S. Meziyerh, A. L. van Rijn, D. van der Helm, P. J. van der Boog, T. van Gelder, A. C. Kroes, J. W. de Fijter, D. J. Moes, J. I. Rotmans, M. C. Feltkamp, A. P. de Vries

  • Early versus Delayed Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients

    A. Hutchins1, M. Leick2, M. Keck2, J. S. McMullen2

  • Early versus Late Ureteral Stent Removal in Pediatric Kidney Transplant Recipients

    A. McGrath1, L. Maestretti1, S. Samreth1, K. Sheth2, P. Grimm2, A. Chaudhuri2, A. Gallo2

  • Early vs. Late Heparin Administration After Declaration of Death in DCD Donors Does Not Impact Short Term Outcomes in Kidney Transplantation

    A. M. Hawxby, R. Ketcham, R. Squires, J. P. Orlowski, H. Solomon, C. Hostetler

  • EBV+ PTLD Tumor MicroRNAs Detected in Circulating Extracellular Vesicles Are Decreased in Pediatric Transplant Recipients with EBV+ PTLD

    A. Sen1, J. Enriquez1, M. Rao1, M. Glass1, Y. Balachandran1, S. Syed1, C. Twist1, K. Weinberg1, S. D. Boyd1, D. Bernstein1, A. Trickey1, D. Gratzinger1, B. Tan1, M. G. Lapasaran1, M. A. Robien2, M. Brown3, B. Armstrong4, M. Sever4, D. Desai5, G. Mazariegos6, C. Chin7, T. Fishbein8, R. S. Venick9, A. Tekin10, H. Zimmermann11, R. U. Trappe12, C. O. Esquivel1, O. M. Martinez1, S. M. Krams1

  • Effect Of A Fourth Covid-19 Vaccine Dose On Omicron Variant Neutralization In Solid Organ Transplant Recipients

    A. Karaba, A. Abedon, J. Alejo, C. X. Qin, D. Warren, J. Ruff, T. Aytenfisu, T. S. Johnston, O. Akinde, A. Pekosz, S. Klein, A. Cox, D. Segev, A. Tobian, W. Werbel

  • Effect of Abdominal Aortic Calcification on Renal Function After Liver Transplantation

    R. Ide, M. Ohira, R. Arata, K. Imaoka, K. Ono, T. Mochizuki, N. Tsukiyama, A. Seidakhmetov, H. Yamane, K. Sato, Y. Imaoka, H. Mashima, D. Marlen, R. Nakano, M. Hashimoto, N. Tanimine, S. Kuroda, H. Tahara, K. Ide, T. Kobayashi, Y. Tanaka, H. Ohdan

  • Effect of Anti Thymocyte Globulin Induction Therapy in Kidney Transplantation Network Meta-Analysis Using Recent Data

    S. Hwang, J. Song, K. Kim, S. Lee

  • Effect of CD8+ Cell Depletion in Treg Mediated Skin Graft Survival

    R. Steiner1, A. M. Weijler1, M. Muckenhuber2, J. Sprent3, T. Wekerle4, N. Pilat1

  • Effect of Covid-19 Diagnosis on Organ Donation and Transplantation

    L. Baetje1, A. Cheng1, S. Sander2, L. Markham2, M. Ott2, J. Finn2, A. Wee3, K. Dyer4, A. Atluri1, D. Jahandar1, M. Moncure4

  • Effect of Covid-19 Vaccination on Markers of Rejection in Heart Transplant Recipients

    Z. Pieters1, E. Bruno1, S. Kim1, S. De Sirkar1, M. Thomas1, S. B. Sharmin2, M. Liebo1, A. Heroux1, N. Clark1, G. Reid1, S. Uprichard2, M. Yu1

  • Effect of Dual Inhibition of DPP4 and SGLT2 on Tacrolimus-Induced Diabetes Mellitus and Nephrotoxicity in Rat Model

    E. Ko, Y. Shin, C. Seung, S. Lim, B. Chung, C. Yang

  • Effect of Immunosuppression Withdrawal After Graft Failure on Re-Kidney Transplantation Outcomes

    J. Ahn1, S. Sandal2, S. Bae1, D. Segev1, M. McAdams-DeMarco1

  • Effect of Micafungin Bridging on Prevention of Invasive Candidiasis Post Lung Transplantation

    C. Baladad1, M. Converse1, K. DeSear1, S. Karimi1, E. Rubido1, G. El Helou2, T. Pasley1

  • Effect of Mycophenolate Mofetil Dosing on Antibody Response to SARS-CoV-2 Vaccination in Heart and Lung Transplant Recipients

    J. Mitchell1, T. P. Chiang1, J. Alejo1, A. Chang1, A. Abedon1, R. Avery1, A. Tobian1, A. Massie1, M. Levan1, D. Warren1, J. Garonzik-Wang2, D. Segev1, W. Werbel1

  • Effect of Prophylactic Treatment of Osteoporosis on the Progression of Bone Mineral Density and Fractures in Lung Transplant Recipients – A Five-Year, Single-Center Experience

    P. Singh1, A. Ross2, J. Mejia1, T. E. Pesavento1, S. Meng1

  • Effect of Sars-CoV-2 Delta Variant on Post-Vaccination COVID-19 Infection in Solid Organ Transplant Recipients

    E. Tuttle1, J. Moon2, T. J. Grazia3, T. Sam4, S. Mathai3

  • Effect of Schisandra Sphenanthera Extract on Pharmacokinetics of Tacrolimus in Pediatric Renal Transplant Recipients

    J. Jiang1, H. Zhang1, X. Su1, S. Wu1, Y. Chen2, W. Chen2, J. Li2, C. Wu2, L. Yang2, L. Liu2, C. Wang2

  • Effect Of The SRTR COVID-19 3-month Carve-out On Program-specific Transplant Outcome Evaluations

    J. Miller1, G. R. Lyden1, D. Zaun1, B. Kasiske2, R. Hirose3, A. Israni2, J. Snyder1

  • Effectiveness and Limitations of PK Analysis in Optimization of Immunosuppressive Therapy for Kidney Transplantation

    M. Okumura, K. Ishiyama, S. Ashimine, Y. Miwa, K. Iwasaki, T. Kobayashi

  • Effectiveness of a Targeted Media Campaign on Engagement and Interest in Living Donation

    L. A. Davis1, A. Livingston2, A. Waterman3

  • Effector T Cells Potentiate Treg Migration to Allografts

    H. Baydoun, M. Fathallah, A. Pena, B. Robinson, G. Camirand

  • Effects of Pre-Lung Transplantation Pulmonary Rehabilitation on Functional Capacity and Quality of Life

    R. M. AlGhofaily

  • Effects of Race, Previous CoV2 Exposure and the Length and Type of Maintenance Immunosuppression on Protective Immunity to COVID19 Vaccine in Solid Organ Transplant Recipients

    A. Choudhary1, M. Lerman2, S. Khan2, J. Hunt2, A. Nikaein3, D. Calianese1, E. Kalu2, D. K. Jaijyan4, W. Honnen1, A. Pinter1

  • Efficacy and Safety of a Delayed Graft Function Protocol in Kidney Transplant Recipients

    V. Vu1, S. Bhayana2, H. Sweiss1, N. Castro1, R. Hall1, J. Nelson1

  • Efficacy and Safety of Angiotensin II Compared to Catecholamine Vasopressors as a First-Line Vasopressor for Perioperative Hypotension in Kidney Transplant Recipients

    G. Urias1, J. Benken1, A. Lichvar2, D. Pierce1, L. Andrews1, K. Dalton3, A. Datta1, H. Nishioka1, E. Benedetti1, S. Benken1

  • Efficacy and Safety of Delayed, Low-Dose Valganciclovir in High-Risk Cytomegalovirus Liver Transplant Recipients

    S. Anders1, A. Freeman1, L. Hutchinson1, U. Kaszubski1, M. Janusek1, A. Hooter2, D. Raymond2, C. Nguyen2

  • Efficacy and Safety of Denosumab on Osteoporosis in Kidney Transplant Recipients

    W. Park, J. Kwon, J. Lim, Y. Kim, J. Paek, K. Jin, S. Han

  • Efficacy and Safety of PCSK-9 Inhibitor, Evolocumab for Lipid Management in Kidney Transplant Recipients

    J. Pandav1, R. Saranu1, S. Muhsin1, N. Murakami1, S. Gabardi1, K. Safa2, A. Chandraker1

  • Efficacy of a Multispecialty, Multidisciplinary Strategy to Improve the Level of Awareness and Control of Cardiovascular Risk Factors After Liver Transplantation

    G. Crespo, L. Sastre, R. García, C. Viñals, A. J. Amor, G. Yago, A. Hervas, L. Sánchez, J. Trabal, J. Molero, L. Escude, G. Pagano, M. Blasco, R. Gilabert, P. Ruiz, J. Colmenero, M. Navasa, E. Ortega

  • Electrospun Poly-ε-Caprolactone Scaffolds Incorporating Decellularized Extracellular Matrix for Suturable Tissue Engineered Small Vascular Graft

    A. Han1, S. Min1, E. Cho1, H. Woo1, A. Cho1, J. Ha1, Y. Ju2, S. Min1

  • Elevated Donor-Derived Cell-Free DNA (dd-cfDNA) in the Early Post-Transplant Period is Associated with an Increased Incidence of Adverse Clinical Outcomes in Kidney Transplant Recipients

    D. Wojciechowski1, A. Patel2, S. Anand3, J. Klein4, A. Paramesh5, P. Sood6, G. Shekhtman7, N. Agrawal7, M. Fei7, K. Qu7, D. C. Brennan8

  • Eliminating Hepatitis C Positive Status from Kidney Donor Profile Index (KDPI) Calculations Results in Improved Transplant Rates and Outcomes in an Elderly Veteran Population

    R. Lopez-Soler1, A. Thorndyke1, C. Trotter1, A. Abadier2, M. Samra1

  • Emphysematous Cystitis in a Lung Transplant Recipient with BK Viremia

    D. Razia, J. Klein, H. Mohamed, A. Arjuna

  • En-Bloc Kidney Transplantation in Children Over a 33-year Period in USA – A Comparative Study

    P. Gogalniceanu1, I. D. Kostakis2, P. Chandak3, G. Papadakis4, J. Stojanovic5, F. Calder4, I. Loukopoulos4, N. Kessaris4

  • End-to-Side Splenic to Hepatic Artery Reconstruction in Liver Transplant: A Case Series

    N. Baker, L. Aviles-Ovalle, T. Baker, J. Campsen, R. Kim, G. Rofaiel

  • Engineered Adaptable Human Endothelial Cells Enable Durable Engraftment of Subcutaneously Transplanted Islets

    R. Craig-Schapiro, G. Li, S. Rafii

  • Engineered IL-2 Plus Calcineurin Inhibitor Synergistically Expands Regulatory T Cells Transduced with Engineered IL-2 Receptor and Facilitates Establishment of Transplantation Tolerance

    T. Hirai1, P. Lin2, T. L Ramos2, K. Garcia3, R. S Negrin2

  • Enhanced Delivery of Nanomedicine to Human Kidney During Ex Vivo Perfusion

    C. Albert1, L. Bracaglia1, A. Koide2, J. R. DiRito1, T. Lysyy1, E. Christopher1, J. Grundler1, J. T. Langford1, D. Haakinson1, J. S. Pober1, W. M. Saltzman1, S. Koide2, G. Tietjen1

  • Enhanced Histological Yield and Actionable Findings When Biopsy is Guided by Donor-Derived Cell-Free DNA (dd-cfDNA)

    M. R. Weir1, D. Mandelbrot2, J. S. Bromberg1, S. Mehta3, E. Poggio4, E. Huang5, G. Shekhtman6, N. Agrawal7, W. Tian8, M. Cooper9

  • Enhancing Early Nerve Regeneration from Reconstruction of a Segmental Nerve Injury with Polyethylene Glycol

    A. Bernal1, C. Hinshaw1, J. Hinshaw1, C. Yang2, S. Margaux1, W. Zhang1, J. Nuelle1, C. Sabbag1, G. Bittner2, J. Shores3, E. Weitzel1, J. Alderete1

  • Epidemiology of Post Transplant Diabetes Mellitus

    S. Al Rasbi, I. Salmi

  • Equity in Access to Deceased Donor Transplant for Candidates on the Heart Waitlist

    K. Bradbrook1, A. Robinson1, R. Goff1, D. Stewart2

  • Equivalence of Pediatric Paper and Electronic-Based Patient-Reported Outcome Measures: Findings from a Systematic Review

    S. Kortbeek1, A. Pawaria2, V. L. Ng1

  • Escalating Waitlist Mortality Above MELD 40: A Rationale to Uncap MELD 3.0?

    A. Kwong, A. Mannalithara, W. Kim

  • ESRD is Increasing Faster After Living Kidney Donation Than it Does in the Unselected US Population: A New Risk Metric?

    R. W. Steiner

  • Establishing a Framework for Long-Term Follow-Up: A Survey of Perspectives and Preferences of Living Kidney Donors

    S. K. Singh1, N. Caton2, O. Johnston2, C. S. Hanson3, A. Dominello3, K. Yetzer4, D. Chang2, A. Tong3, J. S. Gill2

  • Establishing a New Hepatobiliary Surgery Program in a Level 1 Trauma Center Community Teaching Hospital (Our Open and Robotic Experience)

    J. S. Han, S. A. Neubauer, C. E. Renner, C. M. Dunham, T. J. Chirichella

  • Establishment And Validation Of A Predictive Model For Differential Rejection Diagnosis By Gene Expression Profiling (GEP) In Renal Allograft Biopsies Using Banff Human Organ Transplant (B-HOT) Gene Panel

    H. Zhang1, R. Haun2, F. Collin1, C. Cassol2, S. Coley2, J. Wilson2, S. Stone1, K. Qu1, W. Tian1, N. Agrawal1, G. Shekhtman1, C. Larsen2

  • Establishment of an In Vitro Assay to Evaluate Indirect T-cell Allo-Response Using Donor PBMC-Pulsed Dendritic Cells

    K. Iwasaki1, T. Tomosugi2, T. Sekiya3, H. Hamana4, Y. Miwa1, K. Futamura2, M. Okada2, T. Hiramitsu2, N. Goto2, S. Narumi2, Y. Watarai2, H. Kishi4, M. Okumura5, S. Ashimine5, K. Ishiyama5, T. Kobayashi5

  • Estimating the Effect of Increased Donor Heart Ischemic Time on Post-Transplant Survival Using Instrumental Variables

    G. Ran1, K. Lazenby1, N. Narang2, W. F. Parker3

  • Estrogen Receptor Beta Deletion is Protective in Renal Ischemia Reperfusion Injury but Pharmacologic Inhibition of Estrogen Receptor Beta is Not

    C. OBrien1, P. Hernandez2, S. Concors2, Z. Wang1, G. Ge1, W. Hancock3, M. Levine2

  • Ethnic Variation in Adult and Pediatric Liver Transplantation

    N. Kemmer1, M. Malespin1, S. Agrawal1, R. Syed1, K. Alkhalloufi1, B. Alkurdi1, C. Albers1, J. Buggs2

  • Evaluating Long Term Outcomes in Kidney Transplant Patients with TruGraf Gene Expression and TRAC Dd-cfdna in the TRULO Study

    P. West-Thielke, W. Ally, J. Hickey, L. Stach, J. Fleming, T. Cober, A. Kawano, I. Agboli, C. Miller, J. Holman

  • Evaluating the Performance and External Validity of Machine Learning-Based Prediction Models in Liver Transplantation: An International Study

    T. Ivanics1, D. So2, M. P. Claasen3, D. Wallace4, M. Patel5, A. Gravely6, K. Walker7, T. Cowling7, L. Erdman8, G. Sapisochin3

  • Evaluating the Risk and Benefit of Once Daily Delayed Release Mycophenolate in Pediatric Kidney Transplant Recipients

    L. Maestretti1, A. McGrath1, A. Fong1, A. Brubaker2, A. Gallo3, P. Grimm3, A. Chaudhuri3

  • Evaluation of a Change in Pharmacy Discharge Medication Education for Kidney Transplant Recipients

    M. Borsh1, M. Leick1, A. Donovan2, C. McAdam-Marx2, M. Keck1

  • Evaluation of Compliance and Efficacy with Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Tacrolimus in Kidney Transplant Recipients

    M. Nikirk1, J. Chen1, E. Tillman2

  • Evaluation of Conversion from Immediate Release (IR) Tacrolimus to LCP-Tacrolimus (Envarsus XR®, LCP) in Heart Transplant Recipients

    E. Foster1, A. Iaria1, J. Negrelli2, M. Fine2, M. Yu2, M. Liebo2

  • Evaluation of Crushed Posaconazole Delayed Release Tablets in Lung Transplant Recipients

    R. Gordon1, K. Dewey1, R. Jariwala1, B. Yen1, J. Kukreja2, S. Hays2, J. Singer2, R. Florez1

  • Evaluation of Diabetes-Free Life Expectancy Among Living Kidney Donors and Non-Donors with Obesity: A Longitudinal Cohort Study

    C. Killian1, R. Reed1, M. McLeod1, P. MacLennan1, V. Kumar1, S. Brooks1, A. Maynor1, L. Stanford1, G. Baker1, C. Schinstock2, J. Silkensen3, G. Roll4, D. Segev5, B. Orandi1, C. Lewis1, J. Locke1

  • Evaluation of Different Initial Tacrolimus Dosing Regimens in Pediatric Post-Liver Transplantation

    A. F. Alghanem1, A. Alsmari1, H. Joharji2

  • Evaluation of Donor Exclusion Criteria in Living Donor Liver Transplantation: A Single-Center Experience

    D. Daskalaki, M. E. Akoad, J. Kim, C. J. Simon, Y. Cheah

  • Evaluation of Genotype Based Clustering Method of Single-Cell RNA-Sequencing Data from Human Kidney Allograft Biopsies

    G. Thareja1, A. Belkadi1, S. Rahim2, H. Yang2, F. B. Mueller2, K. Suhre1, M. Suthanthiran2, T. Muthukumar2

  • Evaluation of GLP-1 Receptor Agonist Use in the Solid Organ Transplant Population

    S. E. Lawrence, M. R. Norvell, K. Schwarz, B. Crowther, P. Klem

  • Evaluation of Hepatitis C Positive Donor to Hepatitis C Negative Recipient Kidney Transplant in a Highly Sensitized Patient Population

    A. T. Iaria, M. Martin, A. Hietpas, I. Tang, S. Koppe, I. Tzvetanov, E. Benedetti, C. Muran

  • Evaluation of Post-Transplant Angiotensin II Type 1 Receptor Antibodies, Donor-Derived Cell-Free DNA, and Rejection in Heart Transplant Recipients

    B. Agegnehu1, S. Sterling1, R. Winstead1, I. Tchoukina2

  • Evaluation of Prophylactic Valganciclovir Dosing in Kidney Transplant Recipients at an Urban Transplant Institution

    E. Foster1, D. Pierce1, T. Cairns1, S. Borgetti2, I. Tzvetanov3, E. Benedetti3, C. Muran1

  • Evaluation of Renal Function After Donation in Living Marginal Kidney Donor

    S. Harada1, H. Sasaki2, Y. Takada2, D. Takamoto2, T. Hirano2, T. Kan1, Y. Yamagata1, H. Harada2, K. Minami1, K. Moriya1, H. Tanaka1

  • Evaluation of Technical Bladder Complications in Kidney Transplantation Recipients with a Prolonged Dialysis History

    S. M. Zielsdorf, K. Kushwaha, C. Goldbeck, S. Martin, Y. Kwon, K. Etesami, J. Kim, J. Emamaullee, S. Zielsdorf

  • Evaluation of the Management of Cytomegalovirus in Kidney Transplant Recipients After Establishment of a Multidisciplinary Cytomegalovirus Workgroup

    A. Boyle, A. Spenningsby, H. Rhodes, T. Anderson-Haag

  • Evaluation of the Significance of Isolated C4d Staining without Histological Evidence of Rejection on Kidney Biopsies After ABO-Compatible Transplantation in Pediatric Recipients

    C. Duneton1, M. Rabant2, J. Duong-Van-Huyen2, V. Baudouin1, E. Cheyssac1, O. Boyer3, J. Hogan1

  • Evaluation of UW-Based Solutions Formulated to Be Anti-Apoptotic and Neuroprotective of Retinal Ganglion Cells (RGCs) Following Whole Eye Transplantation (WET) in a Rat Model

    N. J. Khatter1, Y. Wang1, B. Li1, C. R. Owens1, A. H. Jani2, C. A. Huang1, R. W. Nickells3, A. A. Su1, K. M. Washington1

  • Evaluation of Voriconazole Dosing for Preventing Aspergillus in Lung Transplant Recipients

    A. Chaplain1, B. J. Pierce1, C. Pham1, A. Hutchins1, W. L. Musick1, D. T. Nguyen2, E. A. Graviss2, S. W. Yau3, J. G. Youssef3, A. Goodarzi3, H. J. Huang3

  • Everolimus Alleviates Renal Allograft Interstitial Fibrosis by Inhibiting Epithelial to Mesenchymal Transition Not Only via Inducing Autophagy but Also via Stabilizing iκB-α

    Z. Gui1, W. Zijie2, M. Zheng3, M. Gu1, R. Tan3

  • Everolimus in Liver Transplantation for Diffuse, Unresectable Neuroendocrine Tumor

    J. M. Vanatta1, R. A. Helmick2, C. Eymard2, N. Nezakatgoo2, P. Horton2, J. P. Kothadia2, S. P. Nair2, J. D. Eason2

  • Everolimus versus Mycophenolate in Simultaneous Pancreas and Kidney Transplantation: Progression of Diabetic Retinopathy in a Prospective Randomized Trial

    B. Hagerf1, Z. Hladíková1, M. Zahradnická1, K. Kesslerová2, T. Sosna2, P. Girman1, F. Saudek1

  • Evidence for Improved Quality of Life Among Chronic Pancreatitis Patients Undergoing Total Pancreatectomy with Islet Autotransplantation Using EORTC QLQ-C30 and QLQ-PAN 26

    M. Coluzzi, B. Naziruddin, G. Saracino, G. Testa, E. Beecherl, N. Onaca

  • Evolution of Cellular and Humoral Immunity During and After a Three Doses-Course of mRNA-1273 COVID-19 Vaccine in Kidney Transplant Recipients

    D. Cucchiari1, N. Egri1, J. Casals-Urquiza2, J. Del Risco-Zevallos1, D. Rodríguez-Espinosa3, E. Montagud-Marrahi2, J. Rovira4, M. Ramirez-Bajo5, E. Banón-Maneus5, P. Ventura-Aguiar2, M. Pascal1, I. Revuelta6, B. Bayès2, F. Diekmann2

  • Evolution of Donation After Circulatory Death Liver Transplantation in the United States

    M. Finotti, G. McKenna, J. Bayer, H. Fernandez, S. Lee, E. Martinez, N. Onaca, G. Saracino, R. Ruiz, G. Testa, A. Gupta, A. Wall

  • Evolution of Donor-Derived Cell-Free DNA During the First Week After Surgery Predicts Renal Function Recovery After Kidney Transplantation

    D. Cucchiari1, E. Cuadrado1, E. Gonzalez1, J. Puig1, M. Ramirez-Bajo1, P. Ventura-Aguiar1, I. Revuelta2, B. Bayès1, F. Diekmann1

  • Evolution of Pretransplant Cardiac Risk Factor Burden and Major Adverse Cardiovascular Events in Liver Transplant Recipients Over Time

    C. Harrington, P. Levy, E. Cabrera, J. Gao, D. Gregory, C. Padilla, G. Crespo, L. VanWagner

  • Evolution of the Need for Transplant Evaluations for Liver Failure Decompensation After TIPS

    N. Kemmer1, V. Sureshkumar2, L. Grater3, G. Hoots4, S. Agrawal1, K. Robichaux5, M. Gosselin3, S. Mohammed5, A. Kumar6, J. Buggs7

  • Evolving Trends In The Management And Outcome Of Duodenal Complications After Pancreas Transplantation: A 20-year Single Institution Experience

    S. Ray1, C. Parmentier1, G. Sapisochin1, A. Yousuf1, I. McGilvray1, A. Norgate1, M. Cattral1, M. Selzner2, T. Reichman3

  • Evs from Patients with Amr Induce Tubular Senescence and Endmt Through Horizontal Transfer of Mirnas

    R. Franzin1, A. Stasi1, F. Sallustio1, S. Bruno2, G. Merlotti3, M. Quaglia3, G. Grandaliano4, P. Pontrelli1, J. Thurman5, G. Camussi2, G. Stallone6, V. Cantaluppi3, L. Gesualdo1, G. Castellano7

  • Ex Vivo End Ischemic Hypothermic Oxygenated Perfusion (hope) Versus Static Cold Storage Prior To Liver Transplantation – Preliminary Results Of The Bridge To Hope Pivotal Multicenter Randomized Controlled Clinical Trial On The Safety And Effectiveness Of The Vitasmart Liver Machine Perfusion System (clinicaltrials.gov: Nct05045794)

    D. J. Reich1, A. Schlegel2, M. Rizzari3, D. Foley4, M. DeVera5, W. Chapman6, G. Roll7, A. Saharia8, C. Quintini9, S. Florman10, S. Merani11, S. Mao12, A. Pinna13, M. Akoad14, C. Kubal15, S. Alexopoulos16, H. Bohorquez17

  • Ex Vivo Liver Resection and Autotransplantation – Should It Be Used More Frequently?

    J. Weiner1, A. Griesemer1, A. Hemming2, D. Levi3, T. Beduschi4, R. Matsumoto1, A. Mathur1, J. Emond1, T. Kato1

  • Ex Vivo Modification of Vascular Allografts Using Immunosuppressive and Anti-Inflammatory Polymers Prevent Rejection via Localized Immunosuppression

    H. D. Luo1, E. M. Siren1, W. Enns2, L. Sim1, C. Du1, S. G. Withers1, J. Choy3, J. N. Kizhakkedathu1

  • Exacerbation of Racial Disparities in Living Donor Kidney Transplant During the Covid-19 Pandemic

    N. Singh1, R. Li2, T. Alhamad3, M. A. Schnitzler4, R. B. Mannon5, M. D. Doshi6, K. J. Woodside6, B. E. Hippen7, M. Cooper8, J. Snyder9, D. A. Axelrod10, K. L. Lentine4

  • Excellent Long-Term Outcome of ABO-Incompatible Living Kidney Transplantation by Reduced-Session of Plasmapheresis of Desensitization Protocol

    Y. Ishiyama1, K. Tanabe2, T. Kanzawa2, K. Unagami2, H. Ishida2, T. Takagi2

  • Excessive Weight Gain Does Not Associate with Poorer Graft Outcomes in Simultaneous Pancreas-Kidney Transplant Recipients – A Single-Center Experience

    N. Eleti, G. Agarwal, S. Ong, C. Kew, D. Anderson, C. Young

  • Exosomal TGFbeta:LAP as Immunosuppressive Mediator of Allo-Tolerance

    W. Burlingham1, E. Jankowska-Gan2, J. Fechner3, C. Little2, J. Sullivan4, D. Foley1

  • Expanded Criteria Donor with Severe Acute Kidney Injury: Worth to Use?

    S. Thotsiri, N. Sutharattanapong, C. Janphram, P. Wiwattanathum

  • Expanded Experience with Ultra-Short Duration Pangenotypic Direct Acting Anti-Viral (DAA) Prophylaxis to Prevent Virus Transmission from Hepatitis C Viremic (HCV) Donors to Hepatitis C Negative Kidney Transplant Recipients (KT)

    I. Yakubu, D. Kumar, A. Sharma, M. Levy, L. Kamal, G. Gupta

  • Expanding Access to Robotic Kidney Transplantation for Candidates with High BMI. A Training Tool for Transplant Centers

    J. A. Almario Alvarez, G. Aguiluz, V. Valle, R. Bustos, S. Akshelyan, A. M. Fratti, P. D. Cocco, M. Spaggiari, I. G. Tzvetanov, E. Benedetti

  • Experience of Over 5 Years and Over 400 Cases of Pure Laparoscopic Donor Right Hepatectomy

    K. Suh, S. Hong, S. Lee, S. Suh, S. Hong, E. Han, Y. Choi, N. Yi, K. Lee

  • Experience Using Intra-Operative Dialysis in Surgically Complex Liver Transplantation

    M. Palascak1, D. Arango1, S. Yockelson1, J. Koveleskie1, D. Ganier1, A. Cohen2, H. Bohorquez2

  • Experience with Covid-19 Infection and Vaccination in Combined Kidney/HSCT Recipients

    M. Gibson1, D. Belshe1, G. Gregory1, S. Tanna1, M. Ison1, S. Ildstad2, J. R. Leventhal1

  • Experience with the First Two Living Donor Robotic Left Lobe Hepatectomies in the USA

    M. E. Tobon Lascano, M. Akoad, C. Simon, J. Kim, Y. Cheah

  • Exploration of the Optimal pH in Hypothermic Machine Perfusion for Rat Liver Grafts Retrieved from Circulatory Death

    S. Sakamoto1, M. Fukai1, K. Shibata1, H. Bochimoto2, N. Mohd Zin2, N. Kawamura1, T. Ishikawa1, M. Fujiyoshi1, T. Shimamura3, A. Taketomi1

  • Exploring Individual Optimal Immunosuppression Management According to the Oncological Risk in Liver Transplanted Patients with Hepatocellular Carcinoma

    K. Sasakik1, S. Kimura2, D. Soma3, K. Tomiyama4, M. Matthew4, M. Fruscione2, C. Kubal3, D. Kwon5

  • Exploring the Differential Access Hypothesis: Do Black Kidney Transplant Candidates Have Less Social Network Access to Potential Living Donors Than White Candidates?

    J. Daw1, M. Roberts1, T. Purnell2

  • Extended Duration of Rabbit Antithymocyte Globulin (rATG) Induction in Kidney and Kidney/Pancreas Transplant Recipients

    D. Majmundar, A. Di Carlo, A. Diamond

  • External Validation of the Abbreviated Ibox Scoring System at One-Year Post Kidney Transplant as a Surrogate Endpoint for Death-Censored Graft Survival

    A. Klein1, L. Kosinski2, R. Muse2, A. Loupy3, O. Aubert3, G. Divard3, M. Stegall4, I. Helanterä5, W. E. Fitzsimmons1, I. O'Doherty1

Jump to:  View All • a b c d [e] f g h i j k l m n o p q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences